Pular para o conteúdo principal
Ranking Invest

BVS - Bioventus Inc.

Segmento: HealthcareBioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Análise Ranking Invest

Valuation estimado
-$ 67.91 Mi
Valor de Mercado
$ 886.60 Mi
Desconto (AV)-1405.5%
IVR
-0.08A companhia vale -0,08 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.25O valuation alternativo equivale a -25% do valor de mercado da companhia.
MLL
-0.25O lucro líquido dos controladores em 16 trimestres equivale a -25% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 179.20 Mi

Dívida Líquida

$ 219.00 Mi

L4T

$ 54.46 Mi

MM4T

8.95%

Indicadores Básicos

ROE

30.39%

Índices de Previsibilidade

Receita Líquida

C0.06

Lucro

D0.96

Margem

D0.70

Índices de Tendência

Receita Líquida

C7.27

Lucro

A8.44

Margem

A8.18

Índices de Endividamento

DIV/PAT

1.22

DIV/L4T

4.02

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.